Extracellular Vesicle Infusion Therapy for Severe COVID-19
Conditions: Covid19; ARDS; Pneumonia, Viral Intervention: Biological: DB-001 Sponsor: Direct Biologics, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials